Mainz, Germany

Tana Omokoko

USPTO Granted Patents = 9 

 

 

Average Co-Inventor Count = 6.3

ph-index = 3

Forward Citations = 58(Granted Patents)


Company Filing History:

goldMedal5 out of 7 
 
Biontech Cell & Gene Therapies Gmbh
 patents
silverMedal2 out of 15 
 
Tron—translationale Onkologie An Der Universitatsmedizin Der Johannes Gutenberg-Universitat Mainz Ggmbh
 patents
bronzeMedal2 out of 3 
 
Translationale Onkologie An Der Universitätsmedizin Der Johannes Gutenberg-Universität Mainz Gemeinnützige Gmbh
 patents
42 out of 23 
 
Tron—translationale Onkologie An Der Universitátsmedizin Der Johannes Gutenberg—universitÄt Mainz Gemeinnützige Gmbh
 patents
51 out of 17 
 
Biontech Rna Pharmaceuticals Gmbh
 patents
61 out of 1 
 
Biotech Cell & Gene Thrapies Gmbh
 patent
71 out of 1 
 
Tron—translationale Onkologie Ander Universitata Tsmedizin Der Johannes Gutenberg-Universitat Main
 patent
81 out of 1 
 
Ganymed Pharmceuticals Ag
 patent
91 out of 66 
 
Biontech Se
 patents
101 out of 1 
 
Translationale Onkologie An Der Universitätsmedizin Der Johannes Gutenbera-Universität Mainz Gemeinnützine Gmbh
 patent
111 out of 2 
 
Biontech Diagnostics Gmbh
 patents
121 out of 1 
 
Tron-translationale Onkologie an Der Universitatsmedzin Der Johannes Gutenberg-universitat Mainz
 patent
131 out of 50 
 
Ganymed Pharmaceuticals Ag
 patents
where one patent can have more than one assignee

Years Active: 2017-2023

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Tana Omokoko: Pioneering Inventor in Immunotherapy

Introduction:

Tana Omokoko, a distinguished inventor based in Mainz, Germany, has made significant contributions to the field of immunotherapy through his groundbreaking innovations. With a total of 9 patents to his name, Omokoko's work is at the forefront of revolutionizing medical treatment.

Latest Patents:

Among his latest patents, Tana Omokoko has introduced Claudin-18.2-specific immunoreceptors and T cell epitopes, as well as Claudin-6-specific immunoreceptors and T cell epitopes. These inventions offer novel approaches to immunotherapy, utilizing targeted immunoreceptors for enhanced treatment efficacy.

Career Highlights:

Having worked at companies like Biontech Cell & Gene Therapies GmbH and TRON-Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz GmbH, Tana Omokoko has honed his expertise in developing cutting-edge medical solutions. His advancements have the potential to reshape the landscape of cancer treatment and beyond.

Collaborations:

Throughout his career, Tana Omokoko has collaborated closely with esteemed colleagues such as Ugur Sahin and Petra Simon. Together, they have spearheaded innovative projects that have garnered acclaim within the scientific community.

Conclusion:

In conclusion, Tana Omokoko's passion for innovation, coupled with his relentless drive to push the boundaries of what is possible, cements his legacy as a trailblazing inventor shaping the future of technology. His pioneering work in immunotherapy holds promise for revolutionizing medical treatment paradigms, making him a prominent figure in the world of inventions and patents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…